D-K6L9
D-K6L9 shows antimicrobial and antibiofilm activities against P. aeruginosa from cystic fibrosis patients. D-K6L9 is stable and resistant to degradation by cystic fibrosis sputum proteases and will not induce bacterial resistance .
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 426264-61-1
- Formule: C90H174N22O15
- Masse moléculaire:1804.48
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Chemical Information
-
CAS No. 426264-61-1
-
Masse moléculaire 1804.48
-
Formule C90H174N22O15
-
Sequence
Leu-Lys-{d-Leu}-Leu-Lys-{d-Lys}-Leu-{d-Leu}-{d-Lys}-Lys-Leu-Leu-{d-Lys}-Leu-Leu-NH2
-
Sequence Shortening
LK-{d-Leu}-LK-{d-Lys}-L-{d-Leu}-{d-Lys}-KLL-{d-Lys}-LL-NH2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)